Phylogica is a specialist drug discovery company which identifies new prototype drug candidates for large Pharmaceutical companies, from within its unique libraries of billions of 'Phylomer' peptides. Phylomer libraries offer a superior quantity (hit rate) and quality (affinity) of drug leads, which have been validated in multiple disease models (www.phylogica.com)